| Literature DB >> 33131168 |
Yuri Uchiyama1,2, Daisuke Yamaguchi3, Kazuhiro Iwama2,4, Satoko Miyatake2,5, Kohei Hamanaka2, Naomi Tsuchida1,2, Hiromi Aoi2,6, Yoshiteru Azuma2, Toshiyuki Itai2, Ken Saida2, Hiromi Fukuda2,7, Futoshi Sekiguchi2, Tomohiro Sakaguchi2, Ming Lei2, Sachiko Ohori2, Masamune Sakamoto2,4, Mitsuhiro Kato8, Takayoshi Koike9, Yukitoshi Takahashi9, Koichi Tanda10, Yuki Hyodo11, Rachel S Honjo12, Debora Romeo Bertola12, Chong Ae Kim12, Masahide Goto13, Tetsuya Okazaki14, Hiroyuki Yamada14, Yoshihiro Maegaki14, Hitoshi Osaka13, Lock-Hock Ngu15, Ch'ng G Siew15, Keng W Teik15, Manami Akasaka16, Hiroshi Doi7, Fumiaki Tanaka7, Tomohide Goto17, Long Guo18, Shiro Ikegawa18, Kazuhiro Haginoya19, Muzhirah Haniffa15, Nozomi Hiraishi20, Yoko Hiraki21, Satoru Ikemoto22, Atsuro Daida22, Shin-Ichiro Hamano22, Masaki Miura23,24, Akihiko Ishiyama23, Osamu Kawano25, Akane Kondo26, Hiroshi Matsumoto27, Nobuhiko Okamoto28, Tohru Okanishi14,29, Yukimi Oyoshi23, Eri Takeshita23, Toshifumi Suzuki6, Yoshiyuki Ogawa30, Hiroshi Handa30, Yayoi Miyazono31, Eriko Koshimizu2, Atsushi Fujita2, Atsushi Takata2, Noriko Miyake2, Takeshi Mizuguchi2, Naomichi Matsumoto2.
Abstract
Many algorithms to detect copy number variations (CNVs) using exome sequencing (ES) data have been reported and evaluated on their sensitivity and specificity, reproducibility, and precision. However, operational optimization of such algorithms for a better performance has not been fully addressed. ES of 1199 samples including 763 patients with different disease profiles was performed. ES data were analyzed to detect CNVs by both the eXome Hidden Markov Model (XHMM) and modified Nord's method. To efficiently detect rare CNVs, we aimed to decrease sequencing biases by analyzing, at the same time, the data of all unrelated samples sequenced in the same flow cell as a batch, and to eliminate sex effects of X-linked CNVs by analyzing female and male sequences separately. We also applied several filtering steps for more efficient CNV selection. The average number of CNVs detected in one sample was <5. This optimization together with targeted CNV analysis by Nord's method identified pathogenic/likely pathogenic CNVs in 34 patients (4.5%, 34/763). In particular, among 142 patients with epilepsy, the current protocol detected clinically relevant CNVs in 19 (13.4%) patients, whereas the previous protocol identified them in only 14 (9.9%) patients. Thus, this batch-based XHMM analysis efficiently selected rare pathogenic CNVs in genetic diseases.Entities:
Keywords: XHMM; copy number variation; exome sequencing; jNord; mendelian disorder
Mesh:
Year: 2020 PMID: 33131168 DOI: 10.1002/humu.24129
Source DB: PubMed Journal: Hum Mutat ISSN: 1059-7794 Impact factor: 4.878